Microstructural and functional brain abnormalities in multiple sclerosis predicted by osteopontin and neurofilament light

被引:14
|
作者
Orsi, Gergely [1 ,2 ]
Cseh, Tamas [2 ]
Hayden, Zsofia [3 ]
Perlaki, Gabor [1 ,2 ]
Nagy, Szilvia Anett [1 ,2 ]
Giyab, Omar [4 ]
Olsen, Dorte Aalund [5 ]
Madsen, Jonna Skov [5 ,6 ]
Berki, Timea [3 ]
Illes, Zsolt [2 ,7 ,8 ]
机构
[1] Eotvos Lorand Res Network ELKH, MTA PTE Clin Neurosci MR Res Grp, Pecs, Hungary
[2] Univ Pecs, Sch Med, Dept Neurol, Pecs, Hungary
[3] Univ Pecs, Sch Med, Dept Immunol & Biotechnol, Pecs, Hungary
[4] Univ Pecs, Sch Med, Dept Med Imaging, Pecs, Hungary
[5] Univ Hosp Southern Denmark, Lillebaelt Hosp, Dept Biochem & Immunol, Vejle, Denmark
[6] Univ Southern Denmark, Dept Reg Hlth Res, Fac Hlth Sci, Odense, Denmark
[7] Odense Univ Hosp, Dept Neurol, JB Winslows Vej 4, DK-5000 Odense, Denmark
[8] Univ Southern Denmark, Dept Clin Res, Odense, Denmark
关键词
Multiple sclerosis; NAWM; Functional connectivity; fMRI; Resting-state; Diffusion; MR spectroscopy; Osteopontin; Neurofilament; DYSFUNCTION; CYTOKINE;
D O I
10.1016/j.msard.2021.102923
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Osteopontin (OPN) is a proinflammatory biomarker, and neurofilament light chain (NFL) levels reflect axonal damage. Resting-state functional MRI (rs-fMRI) defines brain networks during wakeful rest. Objective: To examine, if levels of OPN and NFL are associated on the long term with (i) lesion evolution, (ii) changes in normal-appearing white matter (NAWM) microstructure and (iii) functional connectivity in multiple sclerosis (MS). Methods: Concentration of NFL and OPN in the blood and CSF were related to MRI findings 10.3 +/- 2.8 years later in 53 patients with MS. NFL was examined by Simoa method, OPN by ELISA. Lesion volume in the brain and cervical spinal cord was examined by 3D FLAIR images. Voxel-wise images of fractional anisotropy (FA), axial diffusivity (AD), mean diffusivity (MD), and radial diffusivity (RD) were examined by tract-based spatial statistics corrected for gender, age and lesion volume. Metabolites were examined by single-voxel MR-spectroscopy in the NAWM. Fifty-five default mode network connections were examined by rs-fMRI corrected for gender, age, MS subtype and current therapy as covariates. Results: While NFL in paired serum and CSF positively correlated (p = 0.019), there was no correlation between serum and CSF OPN. Higher OPN levels in the CSF but not in the serum showed association with increased brain WM lesion volume (p = 0.009) in 10.3 +/- 2.8 years. Higher OPN in the CSF was associated with reduced FA, increased MD, and reduced RD in different NAWM areas 10.3 +/- 2.8 years later. Higher OPN in the serum and CSF were associated with increased connectivity strength between the medial prefrontal cortex (MPFC) and other regions except with inferior parietal lobule. NFL in the CSF and in the serum was associated with decreased connectivity strength except for ventral MPFC-hippocampal formation. Neither serum OPN nor NFL at the time of the MRI were associated with functional connectivity changes. Conclusion: While serum NFL levels reflects CNS production, OPN in serum and CSF may have different cellular sources. OPN within the CSF but not in the serum may forecast development of lesions and microstructural abnormalities in 10 years, indicating the detrimental role of CNS inflammation on the long-term. Although both OPN and NFL in the CSF were associated with functional connectivity changes in 10 years, NFL was associated with decreased strength possibly indicating general axonal loss. In contrast, the positive association of OPN levels in the CSF with increased connectivity strength in 10 years may point to adaptive re-organization due to inflammatory WM lesions and microstructural changes.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Vitamin D3 supplementation and neurofilament light chain in multiple sclerosis
    Smolders, Joost
    Mimpen, Max
    Oechtering, Johanna
    Damoiseaux, Jan
    van den Ouweland, Jody
    Hupperts, Raymond
    Kuhle, Jens
    ACTA NEUROLOGICA SCANDINAVICA, 2020, 141 (01): : 77 - 80
  • [32] Serum neurofilament light chain in relapsing multiple sclerosis patients on a ketogenic diet
    Oh, Unsong
    Woolbright, Emma
    Lehner-Gulotta, Diana
    Coleman, Rachael
    Conaway, Mark
    Goldman, Myla D.
    Brenton, J. Nicholas
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 73
  • [33] Impact of serum neurofilament light on clinical decisions in a tertiary multiple sclerosis clinic
    van Lierop, Zoe Y. G. J.
    Wessels, Mark H. J.
    Lekranty, Womei M. L.
    Moraal, Bastiaan
    Hof, Sam N.
    Hogenboom, Laura
    de Jong, Brigit A.
    Meijs, Nandi
    Mensing, Liselore A.
    van Oosten, Bob W.
    Sol, Nik
    Kempen, Zoe L. E. van
    Vermunt, Lisa
    Willems, Myrthe J.
    Strijbis, Eva M. M.
    Uitdehaag, Bernard M. J.
    Killestein, Joep
    Teunissen, Charlotte E.
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (13) : 1620 - 1629
  • [34] Temporal profile of serum neurofilament light in multiple sclerosis: Implications for patient monitoring
    Calabresi, Peter A.
    Arnold, Douglas L.
    Sangurdekar, Dipen
    Singh, Carol M.
    Altincatal, Arman
    de Moor, Carl
    Engle, Bob
    Goyal, Jaya
    Deykin, Aaron
    Szak, Suzanne
    Kieseier, Bernd C.
    Rudick, Richard A.
    Plavina, Tatiana
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (10) : 1497 - 1505
  • [35] Neurofilament light chain as an indicator of exacerbation prior to clinical symptoms in multiple sclerosis
    Edwards, Keith R.
    Garten, Lore
    Button, Judy
    O'Connor, Judy
    Kamath, Vineetha
    Frazier, Carol
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 31 : 59 - 61
  • [36] Neurofilament light chain and MRI volume parameters as markers of neurodegeneration in multiple sclerosis
    Filippi, Pavol
    Vestenicka, Veronika
    Siarnik, Pavel
    Sivakova, Monika
    Copikova-Cudrakova, Daniela
    Belan, Vit'azoslav
    Hanes, Jozef
    Novak, Michal
    Kollar, Branislav
    Turcani, Peter
    NEUROENDOCRINOLOGY LETTERS, 2020, 41 (01) : 17 - 26
  • [37] Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis
    Lorenzo Gaetani
    Nicola Salvadori
    Viviana Lisetti
    Paolo Eusebi
    Andrea Mancini
    Lucia Gentili
    Angela Borrelli
    Emilio Portaccio
    Paola Sarchielli
    Kaj Blennow
    Henrik Zetterberg
    Lucilla Parnetti
    Paolo Calabresi
    Massimiliano Di Filippo
    Journal of Neurology, 2019, 266 : 2157 - 2163
  • [38] Disease biomarkers in multiple sclerosis: current serum neurofilament light chain perspectives
    Jakimovski, Dejan
    Dwyer, Michael G.
    Bergsland, Niels
    Weinstock-Guttman, Bianca
    Zivadinov, Robert
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2021, 11 (04) : 329 - 340
  • [39] Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis
    Brune, Synne
    Hogestol, Einar A.
    de Rodez Benavent, Sigrid A.
    Berg-Hansen, Pal
    Beyer, Mona K.
    Leikfoss, Ingvild Sorum
    Bos, Steffan D.
    Sowa, Piotr
    Brunborg, Cathrine
    Andorra, Magi
    Pulido Valdeolivas, Irene
    Asseyer, Susanna
    Brandt, Alexander
    Chien, Claudia
    Scheel, Michael
    Blennow, Kaj
    Zetterberg, Henrik
    Kerlero de Rosbo, Nicole
    Paul, Friedemann
    Uccelli, Antonio
    Villoslada, Pablo
    Berge, Tone
    Harbo, Hanne F.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (12) : 1859 - 1870
  • [40] Multidimensional overview of neurofilament light chain contribution to comprehensively understanding multiple sclerosis
    Kolliker Frers, Rodolfo A.
    Otero-Losada, Matilde
    Kobiec, Tamara
    Udovin, Lucas D.
    Aon Bertolino, Maria Laura
    Herrera, Maria, I
    Capani, Francisco
    FRONTIERS IN IMMUNOLOGY, 2022, 13